People only know they have ocular hypertension at an eye exam. It doesn’t cause symptoms. Find out how to lower high eye ...

The primary goal of the Ocular Hypertension Treatment Study was to determine the safety and efficacy of topical ocular hypotensive medications in delaying or preventing glaucomatous damage in ...

In the Ocular Hypertension Treatment Study (OHTS) risk estimator, intraocular pressure is an independent variable and risk of developing glaucoma is the dependent variable. In the Threshold to ...

SpyGlass Pharma completed enrollment in a Phase 1/2 trial evaluating its drug delivery platform for glaucoma and ocular ...

POAG is the most common form of glaucoma primarily related to raised intraocular pressure (IOP). 2 The Ocular Hypertension ...

compared selective laser trabeculoplasty and glaucoma eye drops as first-line treatment in patients recently diagnosed with ...

Eligible patients had newly diagnosed OAG or ocular hypertension ... with involvement of one or both eyes received identical treatment. The trial involved 718 patients. Using advanced statistical ...

and in its product candidate PAXTRAVA™ (travoprost intracameral implant or OTX-TIC), which is currently in a Phase 2 clinical ...

SpyGlass prepares for End of Phase II meeting with the FDA to advance its Drug Delivery Platform into Phase III pivotal studiesInnovative ...